DE502004011134D1 - CONCLUSION OF BACTERIA GHOSTS BY BIOAFFINE INTERACTIONS - Google Patents

CONCLUSION OF BACTERIA GHOSTS BY BIOAFFINE INTERACTIONS

Info

Publication number
DE502004011134D1
DE502004011134D1 DE502004011134T DE502004011134T DE502004011134D1 DE 502004011134 D1 DE502004011134 D1 DE 502004011134D1 DE 502004011134 T DE502004011134 T DE 502004011134T DE 502004011134 T DE502004011134 T DE 502004011134T DE 502004011134 D1 DE502004011134 D1 DE 502004011134D1
Authority
DE
Germany
Prior art keywords
ghosts
conclusion
closed
interactions
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE502004011134T
Other languages
German (de)
Inventor
Werner Dr Lubitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE502004011134D1 publication Critical patent/DE502004011134D1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
  • Biological Treatment Of Waste Water (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a method for preparing closed bacterial ghosts by way of specific interactions between partners of a bioaffinity binding pair, and to the bacterial ghosts which can be obtained in this way. Active compounds can be packed into the closed bacterial ghosts. The closed ghosts can be employed in medicine, in the agricultural sphere and in biotechnology.
DE502004011134T 2003-08-05 2004-08-05 CONCLUSION OF BACTERIA GHOSTS BY BIOAFFINE INTERACTIONS Active DE502004011134D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10335796A DE10335796A1 (en) 2003-08-05 2003-08-05 Closure of bacterial ghosts by bioaffine interactions
PCT/EP2004/008790 WO2005011713A1 (en) 2003-08-05 2004-08-05 Sealing of bacterial ghosts by means of bioaffinity interactions

Publications (1)

Publication Number Publication Date
DE502004011134D1 true DE502004011134D1 (en) 2010-06-17

Family

ID=34111931

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10335796A Withdrawn DE10335796A1 (en) 2003-08-05 2003-08-05 Closure of bacterial ghosts by bioaffine interactions
DE502004011134T Active DE502004011134D1 (en) 2003-08-05 2004-08-05 CONCLUSION OF BACTERIA GHOSTS BY BIOAFFINE INTERACTIONS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10335796A Withdrawn DE10335796A1 (en) 2003-08-05 2003-08-05 Closure of bacterial ghosts by bioaffine interactions

Country Status (8)

Country Link
US (1) US7709260B2 (en)
EP (1) EP1656149B1 (en)
AT (1) ATE466586T1 (en)
AU (1) AU2004260620B2 (en)
CA (1) CA2534612C (en)
DE (2) DE10335796A1 (en)
NZ (1) NZ545232A (en)
WO (1) WO2005011713A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2240570T3 (en) 2008-01-18 2014-03-10 Werner Lubitz Bacterial production ghost (BG) using beta-propiolactone (BLP) for final inactivation
US11547662B2 (en) 2017-10-25 2023-01-10 Allero Therapeutics B.V. Treatment of immune diseases by administration of antigen-specific formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19909770A1 (en) * 1999-03-05 2000-09-07 Werner Lubitz Bacterial ghosts as carrier and targeting vehicles
DE10003241A1 (en) * 2000-01-26 2001-08-02 Werner Lubitz Sealing bacterial ghosts
US20030119057A1 (en) * 2001-12-20 2003-06-26 Board Of Regents Forming and modifying dielectrically-engineered microparticles

Also Published As

Publication number Publication date
US7709260B2 (en) 2010-05-04
EP1656149B1 (en) 2010-05-05
ATE466586T1 (en) 2010-05-15
WO2005011713A1 (en) 2005-02-10
CA2534612C (en) 2010-05-11
US20060286126A1 (en) 2006-12-21
AU2004260620B2 (en) 2008-01-24
EP1656149A1 (en) 2006-05-17
NZ545232A (en) 2008-12-24
AU2004260620A1 (en) 2005-02-10
DE10335796A1 (en) 2005-03-03
CA2534612A1 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
Santoyo et al. Rhizosphere colonization determinants by plant growth-promoting rhizobacteria (PGPR)
Peterson et al. A distinguishable role of eDNA in the viscoelastic relaxation of biofilms
Dumas et al. Switching between apparently redundant iron-uptake mechanisms benefits bacteria in changeable environments
MX344592B (en) Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood.
WO2007005955A3 (en) Anti-il-23 antibodies, compositions, methods and uses
NO20062672L (en) Interleukin-10 Antibodies
WO2007076524A3 (en) Human anti-il-23 antibodies, compositions, methods and uses
DK1791860T3 (en) Bacterial cytolysin purification procedure
JO3058B1 (en) Anti-IL-6 Antibodies,Compositions,Methods and uses
MX2008000030A (en) Methods of treating autoimmune disease using humanized anti-cd16a antibodies.
WO2008001224A3 (en) Polypeptides from neisseria meningitidis
ATE483472T1 (en) CD16A BINDING PROTEINS AND USE IN THE TREATMENT OF IMMUNE DISEASES
MY163480A (en) Sclerostin binding agents
ATE516500T1 (en) MAGNETIC PARTICLE CAPTURE FROM WHOLE INTACT ORGANISMS OF CLINICAL SAMPLES
WO2007025977A8 (en) Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis
ATE404181T1 (en) CLOSING BACTERIA GHOSTS
WO2004113500A3 (en) B7s1: an immune modulator
WO2006098621A3 (en) Cross-beta structure on microbial organisms
Pérez-Giménez et al. Soybean lectin enhances biofilm formation by Bradyrhizobium japonicum in the absence of plants
MY185597A (en) Vegetarian protein a preparation and methods thereof
WO2006009525A3 (en) P. aeruginosa mucoid exopolysaccharide specific binding peptides
DE502004011134D1 (en) CONCLUSION OF BACTERIA GHOSTS BY BIOAFFINE INTERACTIONS
ATE458006T1 (en) HUMAN MONOCLONAL ANTIBODIES SPECIFIC TO LIPOPOLYSACCHARIDES (LPS) OF SEROTYPE IATS O6 OF PSEUDOMONAS AERUGINOSA
WO2006123164A3 (en) Lps-binding and bactericidal cytokines and interferons
WO2006000787A3 (en) Antibodies against bacterial antigens and their use in the generation of immune responses against apoptotic cells

Legal Events

Date Code Title Description
8364 No opposition during term of opposition